Effectively addressing cardiovascular risk in people with metabolic-dysfunction associated fatty liver disease: not yet ready for prime time!

被引：0
|
作者：
Koufakis, Theocharis [1 ]
Popovic, Djordje S. [2 ,3 ]
Papadopoulos, Christodoulos [4 ]
Giouleme, Olga [5 ]
Doumas, Michael [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Propedeut Dept Internal Med 2, Thessaloniki 54642, Greece
[2] Univ Novi Sad, Clin Ctr Vojvodina, Clin Endocrinol Diabet & Metab Disorders, Novi Sad, Serbia
[3] Univ Novi Sad, Med Fac, Novi Sad, Serbia
[4] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Dept Cardiol 3, Thessaloniki, Greece
[5] Aristotle Univ Thessaloniki, Hippokrat Gen Hosp, Propedeut Dept Internal Med 2, Gastroenterol & Hepatol Div,Med Sch, Thessaloniki, Greece
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2024年 / 25卷 / 02期
关键词：
MAFLD; cardiovascular risk; MACE; pharmacotherapy; NONALCOHOLIC STEATOHEPATITIS;
D O I：
10.1080/14656566.2024.2312239
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：123 / 126
页数：4
相关论文
共 50 条
  • [21] Metabolic dysfunction associated fatty liver disease and the risk of hepatocellular carcinoma
    Song, Byeong Geun
    Kim, Aryoung
    Choi, Sung Chul
    Goh, Myungji
    Kang, Wonseok
    Gwak, Geum-Yon
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Paik, Seung Woon
    Sinn, Dong Hyun
    JOURNAL OF HEPATOLOGY, 2023, 78 : S631 - S631
  • [22] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [23] Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non-alcoholic fatty liver disease
    Chun, Ho Soo
    Lee, Minjong
    Lee, Jae Seung
    Lee, Hye Won
    Kim, Beom Kyung
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Lee, Yong-Ho
    Kim, Ji-Hye
    Kim, Seung Up
    LIVER INTERNATIONAL, 2023, 43 (03) : 608 - 625
  • [24] Dietary and pharmacological treatment in patients with metabolic-dysfunction associated steatotic liver disease
    Armandi, Angelo
    Bugianesi, Elisabetta
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 122 : 20 - 27
  • [25] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [26] Metabolic-Dysfunction Associated Liver Disease Progresses Independent of Weight in a Rodent Model
    Skinner, Roy
    Alawadi, Ayad
    Warren, Derek
    Benedito, Vagner
    Tou, Janet
    PHYSIOLOGY, 2024, 39
  • [27] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Maurice Michel
    Christian Labenz
    Angelo Armandi
    Leonard Kaps
    Wolfgang Maximilian Kremer
    Peter R. Galle
    Daniel Grimm
    Martin Sprinzl
    Jörn M. Schattenberg
    Scientific Reports, 13
  • [28] Metabolic dysfunction-associated fatty liver disease in people living with HIV
    Michel, Maurice
    Labenz, Christian
    Armandi, Angelo
    Kaps, Leonard
    Kremer, Wolfgang Maximilian
    Galle, Peter R.
    Grimm, Daniel
    Sprinzl, Martin
    Schattenberg, Joern M.
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [29] Metabolic Dysfunction-Associated Fatty Liver Disease Is Associated with the Risk of Incident Cardiovascular Disease: A Prospective Cohort Study in Xinjiang
    Guo, Yanbo
    Yang, Jing
    Ma, Rulin
    Zhang, Xianghui
    Guo, Heng
    He, Jia
    Wang, Xinping
    Cao, Boyu
    Maimaitijiang, Remina
    Li, Yu
    Peng, Xinyu
    Zhang, Shijie
    Guo, Shuxia
    NUTRIENTS, 2022, 14 (12)
  • [30] PARENTAL OBESITY AT PREGNANCY WITH RISK OF METABOLIC-DYSFUNCTION ASSOCIATED STEATOTIC LIVER DISEASE IN YOUNG ADULT OFFSPRING
    Tica, Stefani
    Zong, Xiaoyu
    Tarr, Phillip I.
    Cao, Yin
    GASTROENTEROLOGY, 2024, 166 (05) : S26 - S27
12345